Skip to main content
PMC home page
British Journal of Cancer logoLink to British Journal of Cancer
. 2000 Jan 18;82(3):568–570. doi: 10.1054/bjoc.1999.0965

Lobular carcinoma in situ of the breast is not caused by constitutional mutations in the E-cadherin gene

N Rahman 1,#, J G Stone 1,#, G Coleman 1, B Gusterson 2, S Seal 1, A Marossy 1, S R Lakhani 1,2, A Ward 2, A Nash 3, A McKinna 3, R A'Hern 4, M R Stratton 1, R S Houlston 1
PMCID: PMC2363330  PMID: 10682667

Abstract

Lobular carcinoma in situ (LCIS) is an unusual histological pattern of non-invasive neoplastic disease of the breast occurring predominantly in women aged between 40 and 50 years. LCIS is frequently multicentric and bilateral, and there is evidence that it is associated with an elevated familial risk of breast cancer. Although women with LCIS suffer an increased risk of invasive breast disease, this risk is moderate suggesting that LCIS may result from mutation of a gene or genes conferring a high risk of LCIS, but a lower risk of invasive breast cancer. The high frequency of somatic mutations in E-cadherin in LCIS, coupled with recent reports that germline mutations in this gene can predispose to diffuse gastric cancer, raised the possibility that constitutional E-cadherin mutations may confer susceptibility to LCIS. In order to explore this possibility we have examined a series of 65 LCIS patients for germline E-cadherin mutations. Four polymorphisms were detected but no pathogenic mutations were identified. The results indicate that E-cadherin is unlikely to act as a susceptibility gene for LCIS. © 2000 Cancer Research Campaign

Keywords: LCIS, germline, E-cadherin mutations

Full Text

The Full Text of this article is available as a PDF (47.9 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bartow S. A., Pathak D. R., Black W. C., Key C. R., Teaf S. R. Prevalence of benign, atypical, and malignant breast lesions in populations at different risk for breast cancer. A forensic autopsy study. Cancer. 1987 Dec 1;60(11):2751–2760. doi: 10.1002/1097-0142(19871201)60:11<2751::aid-cncr2820601127>3.0.co;2-m. [DOI] [PubMed] [Google Scholar]
  2. Berx G., Becker K. F., Höfler H., van Roy F. Mutations of the human E-cadherin (CDH1) gene. Hum Mutat. 1998;12(4):226–237. doi: 10.1002/(SICI)1098-1004(1998)12:4<226::AID-HUMU2>3.0.CO;2-D. [DOI] [PubMed] [Google Scholar]
  3. Berx G., Cleton-Jansen A. M., Nollet F., de Leeuw W. J., van de Vijver M., Cornelisse C., van Roy F. E-cadherin is a tumour/invasion suppressor gene mutated in human lobular breast cancers. EMBO J. 1995 Dec 15;14(24):6107–6115. doi: 10.1002/j.1460-2075.1995.tb00301.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Berx G., Cleton-Jansen A. M., Strumane K., de Leeuw W. J., Nollet F., van Roy F., Cornelisse C. E-cadherin is inactivated in a majority of invasive human lobular breast cancers by truncation mutations throughout its extracellular domain. Oncogene. 1996 Nov 7;13(9):1919–1925. [PubMed] [Google Scholar]
  5. Beute B. J., Kalisher L., Hutter R. V. Lobular carcinoma in situ of the breast: clinical, pathologic, and mammographic features. AJR Am J Roentgenol. 1991 Aug;157(2):257–265. doi: 10.2214/ajr.157.2.1853802. [DOI] [PubMed] [Google Scholar]
  6. Cannon-Albright L. A., Thomas A., Goldgar D. E., Gholami K., Rowe K., Jacobsen M., McWhorter W. P., Skolnick M. H. Familiality of cancer in Utah. Cancer Res. 1994 May 1;54(9):2378–2385. [PubMed] [Google Scholar]
  7. Claus E. B., Risch N., Thompson W. D., Carter D. Relationship between breast histopathology and family history of breast cancer. Cancer. 1993 Jan 1;71(1):147–153. doi: 10.1002/1097-0142(19930101)71:1<147::aid-cncr2820710124>3.0.co;2-v. [DOI] [PubMed] [Google Scholar]
  8. De Leeuw W. J., Berx G., Vos C. B., Peterse J. L., Van de Vijver M. J., Litvinov S., Van Roy F., Cornelisse C. J., Cleton-Jansen A. M. Simultaneous loss of E-cadherin and catenins in invasive lobular breast cancer and lobular carcinoma in situ. J Pathol. 1997 Dec;183(4):404–411. doi: 10.1002/(SICI)1096-9896(199712)183:4<404::AID-PATH1148>3.0.CO;2-9. [DOI] [PubMed] [Google Scholar]
  9. Foote F. W., Stewart F. W. Lobular carcinoma in situ: A rare form of mammary cancer. Am J Pathol. 1941 Jul;17(4):491–496.3. doi: 10.3322/canjclin.32.4.234. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Frykberg E. R., Santiago F., Betsill W. L., Jr, O'Brien P. H. Lobular carcinoma in situ of the breast. Surg Gynecol Obstet. 1987 Mar;164(3):285–301. [PubMed] [Google Scholar]
  11. Ganguly A., Rock M. J., Prockop D. J. Conformation-sensitive gel electrophoresis for rapid detection of single-base differences in double-stranded PCR products and DNA fragments: evidence for solvent-induced bends in DNA heteroduplexes. Proc Natl Acad Sci U S A. 1993 Nov 1;90(21):10325–10329. doi: 10.1073/pnas.90.21.10325. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Gayther S. A., Gorringe K. L., Ramus S. J., Huntsman D., Roviello F., Grehan N., Machado J. C., Pinto E., Seruca R., Halling K. Identification of germ-line E-cadherin mutations in gastric cancer families of European origin. Cancer Res. 1998 Sep 15;58(18):4086–4089. [PubMed] [Google Scholar]
  13. Guilford P., Hopkins J., Harraway J., McLeod M., McLeod N., Harawira P., Taite H., Scoular R., Miller A., Reeve A. E. E-cadherin germline mutations in familial gastric cancer. Nature. 1998 Mar 26;392(6674):402–405. doi: 10.1038/32918. [DOI] [PubMed] [Google Scholar]
  14. Keller G., Vogelsang H., Becker I., Hutter J., Ott K., Candidus S., Grundei T., Becker K. F., Mueller J., Siewert J. R. Diffuse type gastric and lobular breast carcinoma in a familial gastric cancer patient with an E-cadherin germline mutation. Am J Pathol. 1999 Aug;155(2):337–342. doi: 10.1016/S0002-9440(10)65129-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Lakhani S. R., Collins N., Sloane J. P., Stratton M. R. Loss of heterozygosity in lobular carcinoma in situ of the breast. Clin Mol Pathol. 1995 Apr;48(2):M74–M78. doi: 10.1136/mp.48.2.m74. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Levi F., Te V. C., Randimbison L., La Vecchia C. Trends of in situ carcinoma of the breast in Vaud, Switzerland. Eur J Cancer. 1997 May;33(6):903–906. doi: 10.1016/s0959-8049(97)00048-8. [DOI] [PubMed] [Google Scholar]
  17. Millikan R., Dressler L., Geradts J., Graham M. The need for epidemiologic studies of in-situ carcinoma of the breast. Breast Cancer Res Treat. 1995 Jul;35(1):65–77. doi: 10.1007/BF00694747. [DOI] [PubMed] [Google Scholar]
  18. Moll R., Mitze M., Frixen U. H., Birchmeier W. Differential loss of E-cadherin expression in infiltrating ductal and lobular breast carcinomas. Am J Pathol. 1993 Dec;143(6):1731–1742. [PMC free article] [PubMed] [Google Scholar]
  19. Ottesen G. L., Graversen H. P., Blichert-Toft M., Zedeler K., Andersen J. A. Lobular carcinoma in situ of the female breast. Short-term results of a prospective nationwide study. The Danish Breast Cancer Cooperative Group. Am J Surg Pathol. 1993 Jan;17(1):14–21. doi: 10.1097/00000478-199301000-00002. [DOI] [PubMed] [Google Scholar]
  20. Page D. L., Kidd T. E., Jr, Dupont W. D., Simpson J. F., Rogers L. W. Lobular neoplasia of the breast: higher risk for subsequent invasive cancer predicted by more extensive disease. Hum Pathol. 1991 Dec;22(12):1232–1239. doi: 10.1016/0046-8177(91)90105-x. [DOI] [PubMed] [Google Scholar]
  21. Takeichi M. Morphogenetic roles of classic cadherins. Curr Opin Cell Biol. 1995 Oct;7(5):619–627. doi: 10.1016/0955-0674(95)80102-2. [DOI] [PubMed] [Google Scholar]
  22. Vos C. B., Cleton-Jansen A. M., Berx G., de Leeuw W. J., ter Haar N. T., van Roy F., Cornelisse C. J., Peterse J. L., van de Vijver M. J. E-cadherin inactivation in lobular carcinoma in situ of the breast: an early event in tumorigenesis. Br J Cancer. 1997;76(9):1131–1133. doi: 10.1038/bjc.1997.523. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES